$12.39
-0.5-3.88%
Pre-Market: 7:45 PM EDT
15 minutes delayed
Comments
Loading...
Cadrenal Therapeutics (CVKD) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestCadrenal Therapeutics (NASDAQ:CVKD) Stock Quotes, Forecast and News Summary
Cadrenal Therapeutics Stock (NASDAQ: CVKD) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Cadrenal Therapeutics (CVKD) stock?
You can purchase shares of Cadrenal Therapeutics (NASDAQ:CVKD) through any online brokerage.
Who are Cadrenal Therapeutics (CVKD) competitors?
Other companies in Cadrenal Therapeutics’s space includes: Cingulate (NASDAQ:CING), Cumberland (NASDAQ:CPIX), Cocrystal Pharma (NASDAQ:COCP), Kiora Pharmaceuticals (NASDAQ:KPRX) and Universe Pharmaceuticals (NASDAQ:UPC).
What is the forecast, or price target, for Cadrenal Therapeutics (CVKD) stock?
Cadrenal Therapeutics has a consensus price target of $3.50.
What is the current price for Cadrenal Therapeutics (CVKD)?
The stock price for Cadrenal Therapeutics (NASDAQ: CVKD) is $12.39 last updated October 1, 2024 at 7:45 PM EDT.
Does Cadrenal Therapeutics (CVKD) pay a dividend?
There are no upcoming dividends for Cadrenal Therapeutics.
When is Cadrenal Therapeutics (NASDAQ:CVKD) reporting earnings?
Cadrenal Therapeutics’s Q3 earnings are confirmed for Friday, November 8, 2024.
Is Cadrenal Therapeutics (CVKD) going to split?
There is no upcoming split for Cadrenal Therapeutics.
What sector and industry does Cadrenal Therapeutics (CVKD) operate in?
Cadrenal Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.